Author

J. Golab

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Approach:deep learning· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

D. Nowis· 4 shared J. Jemielity· 2 shared J. Kowalska· 2 shared T. Spiewla· 2 shared A. Brouze· 1 shared A. Dziembowski· 1 shared A. Mamot· 1 shared A. Piekielko-Witkowska· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

D. Nowis

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1α in pulmonary epithelial and endothelial cells

M. Abrozek-Latecka, P. Kozlowski, G. Hoser, M. Bandyszewska, K. Hanusek, D. Nowis, J. Golab, M. Grzanka, A. Piekielko-Witkowska, L. Schulz, F. Hornung, S. Deinhardt-Emmer, E. Kozlowska, T. Skirecki

This study shows SARS-CoV-2 viroporins ORF3a, E, and M activate inflammasomes in macrophages and induce IL-1α release in pulmonary epithelial and endothelial cells, contributing to immunothrombosis in COVID-19.

bioRxiv · Nov 13, 2023 · PreprintImmunology

Trinucleotide mRNA cap analog N6-benzylated at the site of posttranscriptional m6Am mark facilitates mRNA purification and confers superior translational properties in vitro and in vivo

M. Warminski, E. Trepkowska, M. Smietanski, P. J. Sikorski, M. R. Baranowski, M. Bednarczyk, H. Kedzierska, B. Majewski, A. Mamot, D. Papiernik, A. Popielec, R. Serwa, B. A. Shimanski, P. Sklepkiewicz, M. Sklucka, , J. Kowalska

This paper introduces a modified mRNA cap analog, AvantCap, which improves mRNA purification and translational efficiency in vitro and in vivo.

bioRxiv · Nov 10, 2023 · PreprintBiochemistry

SARS-CoV-2 mRNA vaccine is re-adenylated in vivo, enhancing antigen production and immune response

P. S. Krawczyk, O. Gewartowska, M. Mazur, W. Orzel, K. Matylla-Kulinska, S. Jelen, P. Turowski, T. Spiewla, B. Tarkowski, A. Tudek, A. Brouze, A. Wesolowska, D. Nowis, J. Golab, J. Kowalska, , S. Mroczek

This study shows that SARS-CoV-2 mRNA vaccines are re-adenylated in vivo, increasing antigen production and immune response in macrophages.

bioRxiv · Dec 1, 2022 · PreprintImmunology

Potent but transient immunosuppression of T-cells is a general feature of CD71+ erythroid cells

T. M. Grzywa, A. Sosnowska, Z. Rydzynska, M. Lazniewski, D. Plewczynski, K. Klicka, M. Malecka-Gieldowska, A. Rodziewicz-Lurzynska, O. Ciepiela, M. Justyniarska, P. Pomper, M. M. Grzybowski, R. Blaszczyk, M. Wegrzynowicz, A. Tomaszewska, , D. Nowis

This study shows that CD71+ erythroid cells (CECs) suppress T-cell responses through ARG and ROS mechanisms, but lose this ability as they differentiate into mature erythrocytes.

bioRxiv · Jan 18, 2021Immunology